We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Oxford Biodynamics Plc | LSE:OBD | London | Ordinary Share | GB00BD5H8572 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.02 | 3.17% | 0.65 | 0.60 | 0.70 | 0.65 | 0.65 | 0.65 | 460,714 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.34M | -10.83M | -0.0347 | -0.19 | 1.96M |
Date | Subject | Author | Discuss |
---|---|---|---|
16/1/2024 21:02 | Hopefully a good update tomorrow | hatfullofsky | |
15/1/2024 20:55 | Funding at 15p. | thehitman1 | |
15/1/2024 16:37 | Pump and dump | thehitman1 | |
14/1/2024 12:07 | Or, alternatively, you could take rime to investigate before spouting nonsense. | sav1965 | |
13/1/2024 19:41 | So....is the OBD test simply a DNA/genome test ...& not a prostate test AT ALL, despite the hype. & many companies are able to do DNA/genome tests So, OBD has no moat keeping out competition & protecting it's % margin. And OBD does not make or offer a prostate cancer test, despite the hype/P.R. ----- Can anyone justify/explain how/why I am wrong ? | smithie6 | |
11/1/2024 17:31 | Thanks W. JIT Friday, cost me 2pts! However, correct decision. US of A obviously very keen. | dudishes | |
11/1/2024 09:14 | Notice of Results and Investor Webinar 21 December 2023 - Oxford BioDynamics Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests based on the EpiSwitch(R) 3D genomics platform expects to announce its results for the year ended 30 September 2023 on Wednesday 17 January 2024. | hsdeo1 | |
11/1/2024 08:58 | WOW A NICE JUMP AS 16th JANUARY APPROACED | waldron | |
11/1/2024 06:28 | Needs to keep riding before the results but maybe something is brewing behind the scenes | applepieinthesky | |
10/1/2024 16:48 | Nice rise today, results due next week. Hopefully some good sales growth and an update on the prostate test plans. | hatfullofsky | |
10/1/2024 14:04 | Hitman you really are a thickie aren't you | jambam | |
10/1/2024 13:52 | Rns last year. People forget. Means they now have good revenue coming in | babbler | |
10/1/2024 13:47 | Where did you hear/read this please? | rajraj b | |
10/1/2024 13:38 | Looks like something is up. | rajraj b | |
10/1/2024 12:44 | Watch the pumpers dump | thehitman1 | |
10/1/2024 12:43 | Pump and dump | thehitman1 | |
09/1/2024 08:37 | Do you mean Sail ? | hooded claw | |
08/1/2024 08:19 | Looks likely to rise again today already good positive volume | applepieinthesky | |
05/1/2024 16:31 | Notice of Results and Investor Webinar 21 December 2023 - Oxford BioDynamics Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests based on the EpiSwitch(R) 3D genomics platform expects to announce its results for the year ended 30 September 2023 on Wednesday 17 January 2024. Following release of the results, the Company's management team will conduct a live presentation via the Yellowstone Advisory webinar platform to investors, at 3pm GMT on Wednesday 17 January 2024. THINGS SHOULD BECOME CLEARER AS TO OUTLOOK AD RESULTS APPROACHED CHUCKLE AND CHEERS | waldron | |
05/1/2024 16:13 | GOOD LUCK TO ALL THOSE THAT SALE IN HER | waldron | |
02/1/2024 17:02 | Held up well, considering the 65k sell reported late | hatfullofsky | |
02/1/2024 08:41 | No interest at all. | thehitman1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions